When to contact your GP or prescriber: Injection site symptoms persisting beyond 3-4 days Concerns about injection technique or medication administration Difficulty adhering to treatment due to pain or anxiety Questions about managing minor injection site reactions Any unexpected or concerning symptoms following injection Maintaining open communication with your healthcare team ensures optimal treatment outcomes and allows prompt identification and management of any complications
Every infusion is GP-prescribed, clinically delivered, and individually tailored, with clear protocols, screening, and follow-up to prioritise safety, precision, and personalised care
Gently tap into the skin to absorb.2
These include Wellbutrin (bupropion) and Intuniv (guanfacine)
These key announcements underscore the continued transformation of the metabolic disease landscape, where innovation is increasingly focused on efficacy, accessibility and patient adherence
The injection site reaction typically stems from three sources: needle trauma to tissue, the body's initial inflammatory response to the foreign substance, and individual variation in skin sensitivity